Akash Patel MD*
Akash Patel MD1*, Utsav Vaghani MD2, Sarang Tusharbhai Mehta MD3
1Department of Internal Medicine, Eisenhower Medical Centre, Rancho Mirage, California, USA
2Department of Internal Medicine, UNM Children Hospital, Surat, Gujarat, India
3Department of Internal Medicine, Smt. N.H.L. Municipal Medical College, Ahmedabad, Gujarat, IndiaFulltext PDF
Helicobacter pylori (H. pylori) infection is associated with an increased risk of cardiovascular diseases (CVD), with variable prevalence rates worldwide. The pathogen contributes to CVD through mechanisms such as inflammation, lipid metabolism dysregulation, and enhanced platelet aggregation, which are linked to atherosclerosis development. Treatment typically involves antibiotics and proton pump inhibitors, and may confer additional cardiovascular benefits by addressing the bacterium's systemic effects. Future research should focus on the long-term impact of H. pylori eradication on CVD risk and outcomes, potentially informing prevention strategies. This review underscores the necessity for a comprehensive understanding of H. pylori's implications for cardiovascular health.
Akash Patel MD, Utsav Vaghani MD, Sarang Tusharbhai Mehta.Exploring the Link Between Helicobacter pylori Infection and Cardiovascular Disease Risk: Clinical Implications and Future Research. Int Jour Gastro Hepat. 2023;2(2):1-4.